Literature DB >> 8110955

Tularemia: treatment failures with outpatient use of ceftriaxone.

J T Cross1, R F Jacobs.   

Abstract

Tularemia, an infection caused by the coccobacillus Francisella tularensis, can be a difficult disease process to diagnose and treat. The difficulty in treating this disease is related to the pathophysiology of the infection and the toxicity of the antimicrobial agents presently recommended for treatment. Recent in vitro data have suggested that antimicrobial drugs other than standard agents (streptomycin, gentamicin, chloramphenicol, or tetracycline) may be effective. We present eight cases of documented failure of outpatient use of ceftriaxone in the treatment of tularemia. Our data suggest that while ceftriaxone may have excellent MICs in vitro, these MICs do not necessarily correlate with successful in vivo outcomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8110955     DOI: 10.1093/clinids/17.6.976

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Francisella novicida bacteremia after a near-drowning accident.

Authors:  Meghan Brett; Avanthi Doppalapudi; Laurel B Respicio-Kingry; Debra Myers; Brigitte Husband; Kerry Pollard; Paul Mead; Jeannine M Petersen; Cynthia J Whitener
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

Review 3.  Tularemia: a rare cause of neck mass, evaluation of 33 patients.

Authors:  Sedat Cağlı; Alperen Vural; Onur Sönmez; Imdat Yüce; Ercihan Güney
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-04       Impact factor: 2.503

4.  Bactericidal activities of antibiotics against intracellular Francisella tularensis.

Authors:  M Maurin; N F Mersali; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

5.  Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens.

Authors:  Robin Ireland; Norma Olivares-Zavaleta; Jonathan M Warawa; Frank C Gherardini; Clayton Jarrett; B Joseph Hinnebusch; John T Belisle; Jeffery Fairman; Catharine M Bosio
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

Review 6.  Tularemia presenting as tonsillopharyngitis and cervical lymphadenitis: a case report and review of the literature.

Authors:  Osman Kürşat Arikan; Can Koç; Onder Bozdoğan
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-01-10       Impact factor: 2.503

7.  Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood.

Authors:  Kiersten J Kugeler; Paul S Mead; Karin L McGowan; Jon M Burnham; Michael D Hogarty; Eduardo Ruchelli; Kerry Pollard; Brigitte Husband; Caryn Conley; Tanya Rivera; Theodoros Kelesidis; Walter M Lee; Walburga Mabey; Jonas M Winchell; Heather L Stang; J Erin Staples; Linda J Chalcraft; Jeannine M Petersen
Journal:  J Clin Microbiol       Date:  2008-05-21       Impact factor: 5.948

Review 8.  Tularemia.

Authors:  Jill Ellis; Petra C F Oyston; Michael Green; Richard W Titball
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

9.  A new dye uptake assay to test the activity of antibiotics against intracellular Francisella tularensis.

Authors:  Vivien Sutera; Yvan Caspar; Sandrine Boisset; Max Maurin
Journal:  Front Cell Infect Microbiol       Date:  2014-03-18       Impact factor: 5.293

Review 10.  New therapeutic approaches for treatment of tularaemia: a review.

Authors:  Sandrine Boisset; Yvan Caspar; Vivien Sutera; Max Maurin
Journal:  Front Cell Infect Microbiol       Date:  2014-03-28       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.